Biomaterials offer a promising approach to repair bone defects. Whereas traditional studies
predominantly focused on optimizing the osteogenic capacity of biomaterials, less focus has …

Wharton's jelly‐derived mesenchymal stem cells (WJ‐MSCs) are emerging as a promising
source for bone regeneration in the treatment of bone defects. Previous studies have …

Recently, cases of bone defects have been increasing incrementally. Thus, repair or
replacement of bone defects is gradually becoming a huge problem for orthopaedic …

An ideal scaffold must provide biomimetic conditions similar to an extracellular matrix (ECM)
which is a challenge for tissues with a slow healing rate. As a new biopolymer …

A biomimetic coating was prepared on β-titanium alloy surface using micro-arc oxidation to
enhance its bone regeneration property in diabetic environment. The research probed into …

Wharton's Jelly (WJ) has attracted significant interest in the field of tissue healing thanks to
its biological properties, including antibacterial activity and immunomodulation. However …

Human Wharton's jelly stem cells (HWJSC) can be efficiently isolated from the umbilical
cord, and numerous reports have demonstrated that these cells can differentiate into several …

In vitro models of primary human osteocytes embedded in natural mineralized matrix without
artificial scaffolds are lacking. We have established cell culture conditions that favored the …

Mesenchymal stem cells (MSCs) are considered primary candidates for treating complex
bone defects in cell-based therapy and tissue engineering. Compared with monolayer …

A multifunctional material system that kills bacteria and drives bone healing is urgently
sought to improve bone prosthesis. Herein, the osteoinductive coating made of calcium …